MedTrace Logo

Visual and Patient Reported Outcomes With Clareon TruPlus

NCT07648355 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-06-15

No results posted yet for this study

Summary

This is a prospective, single-site, two-surgeon, single-arm, observational study evaluating the Clareon TruPlus IOL. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the IOLSAT Questionnaire.

Conditions

  • Cataract

Interventions

DEVICE

Clareon TruPlus

Clareon TruPlus

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • OVO LASIK + Lens

    lead OTHER

Principal Investigators

  • Martha Whiting, MD · OVO Lasik and Lens LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-02
Primary Completion
2027-07-11
Completion
2027-07-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07648355 on ClinicalTrials.gov